IKT Competitors & Alternatives
Compare Inhibikase Therapeutics Inc with similar stocks in the same industry
Biotechnology
IKT
Main Stock$2.50
Tradestie Score
45
Market Cap
$119.97M
Revenue Growth
-1.0%
Analyst Upside
+140.0%
Top Competitors
241 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$14.70
|
$371.64M | - | 34 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$21.82
|
$354.45M | - | 31 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$48.21
|
$353.70M | - | 38 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.61
|
$350.98M | - | 54 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$3.11
|
$341.56M | - | 43 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$5.06
|
$332.96M | - | 40 | Compare |
|
REPL
Replimune Group, Inc.
|
$14.71
|
$328.62M | - | 29 | Compare |
|
CTNM
Contineum Therapeutics, Inc. Class A Common Stock
|
$16.63
|
$308.74M | - | 40 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$12.86
|
$304.12M | - | 36 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$21.33
|
$297.23M | - | 46 | Compare |
More IKT Analysis
Data updated: Aug 24, 2026 | Industry: Biotechnology (SIC 2836)
241 stocks in this industry